JP Morgan Chase
CDLX icon

JP Morgan Chase’s Cardlytics CDLX Stock Holding History

JP Morgan Chase’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$872 Buy
+179
New +$1.34K ﹤0.01% 7346
2025
Q2 		– Sell
-2,023
Closed -$36.8K – 7129
2025
Q1 		$36.8K Buy
2,023
+155
+8% +$4.43K ﹤0.01% 5972
2024
Q4 		$69.3K Buy
1,868
+60
+3% +$2.3K ﹤0.01% 5893
2024
Q3 		$57.9K Buy
1,808
+23
+1% +$1.28K ﹤0.01% 5940
2024
Q2 		$147K Sell
1,785
-1,828
-51% -$198K ﹤0.01% 5324
2024
Q1 		$523K Buy
3,613
+1,183
+49% +$99.9K ﹤0.01% 4766
2023
Q4 		$224K Buy
2,430
+137
+6% +$13.9K ﹤0.01% 5333
2023
Q3 		$378K Sell
2,293
-412
-15% -$53.5K ﹤0.01% 4645
2023
Q2 		$171K Sell
2,705
-4,088
-60% -$248K ﹤0.01% 5170
2023
Q1 		$231K Sell
6,793
-1,527
-18% -$79.8K ﹤0.01% 4974
2022
Q4 		$480K Buy
8,320
+296
+4% +$18.3K ﹤0.01% 4549
2022
Q3 		$754K Sell
8,024
-7,220
-47% -$1.03M ﹤0.01% 4213
2022
Q2 		$3.4M Sell
15,244
-195,171
-93% -$65.4M ﹤0.01% 3115
2022
Q1 		$116M Buy
210,415
+4,422
+2% +$2.67M 0.01% 778
2021
Q4 		$136M Buy
205,993
+22,268
+12% +$17M 0.02% 737
2021
Q3 		$154M Buy
183,725
+6,286
+4% +$6.38M 0.02% 675
2021
Q2 		$225M Sell
177,439
-9,236
-5% -$10.4M 0.03% 566
2021
Q1 		$205M Buy
186,675
+41,546
+29% +$54.9M 0.03% 563
2020
Q4 		$207M Buy
145,129
+74,576
+106% +$79.5M 0.03% 516
2020
Q3 		$49.4M Buy
70,553
+9,784
+16% +$7.11M 0.01% 977
2020
Q2 		$42.5M Buy
60,769
+24,984
+70% +$14.4M 0.01% 967
2020
Q1 		$12.5M Buy
35,785
+32,590
+1,020% +$23.1M ﹤0.01% 1571
2019
Q4 		$2.01M Sell
3,195
-25,755
-89% -$12.6M ﹤0.01% 3381
2019
Q3 		$9.7M Buy
28,950
+9,020
+45% +$2.89M ﹤0.01% 2155
2019
Q2 		$4.9M Buy
19,930
+12,759
+178% +$2.55M ﹤0.01% 2677
2019
Q1 		$1.19M Buy
7,171
+2,965
+70% +$482K ﹤0.01% 3698
2018
Q4 		$455K Buy
4,206
+2,745
+188% +$463K ﹤0.01% 4179
2018
Q3 		$365K Sell
1,461
-3,854
-73% -$829K ﹤0.01% 4429
2018
Q2 		$1.16M Buy
5,315
+5,205
+4,732% +$963K ﹤0.01% 3747
2018
Q1 		$16K Buy
+110
New +$18.6K ﹤0.01% 5115

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase's CDLX Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Cardlytics (CDLX) in Q2 2026: 179 shares worth $872. The stake represents ﹤0.01% of the portfolio and ranks #7346 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in CDLX as recently as Q1 2025.

JP Morgan Chase first reported a position in CDLX in Q1 2018 and has held it in 30 quarters since. The position peaked at $225M in Q2 2021. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • JP Morgan Chase held 179 shares of Cardlytics worth $872 as of Q2 2026.
  • Cardlytics was a new JP Morgan Chase position in Q2 2026.
  • Cardlytics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7346 holding.
  • JP Morgan Chase first reported a position in Cardlytics in Q1 2018 and has held it in 30 quarters since.
  • JP Morgan Chase's Cardlytics position peaked at $225M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.